Huron Consulting Group Inc. (HURN)
適正価値ファンダメンタル
70
株価
$169.14
時価総額
$2.50B
パート1 · 企業の価値
概要
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users
Guidehouse, which absorbed Navigant's healthcare practice, sells the same hospital and health-system performance improvement, revenue cycle and research administration advisory that Huron's Healthcare and Education segments live on.
Chartis is a pure-play healthcare advisory firm bidding for the same strategy, clinical and operational transformation projects at US hospitals and academic medical centers that make up Huron's largest segment.
FTI's corporate finance and business transformation practice competes with Huron for performance improvement, restructuring and financial advisory mandates from the same US corporate and healthcare clients.
Accenture competes head-on with Huron's Digital capability, implementing the same Oracle, Workday and Salesforce platforms for health systems and universities, with far greater scale.
Deloitte's healthcare and higher-education consulting practices pursue the same hospital and university transformation budgets, and Huron's 10-K names the consulting arms of the major accounting firms among its competitors.
ICF sells advisory and technology implementation services to public-sector, health and research institutions, overlapping with Huron's Education and Commercial segments.
貸借対照表と流動性
売上高
$1.75B
直近12か月（2026/3/31まで）
純利益
$104M
直近12か月（2026/3/31まで）
フリーキャッシュフロー
$183M
自己資本合計
$529M
負債合計
$998M
流動比率
2.22
利払い倍率
-
負債/EBITDA
4.21
一株当たり利益（EPS）
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$183.81
現在株価
$169.14
安全マージン
+8.0%
適正価値レンジ
$119.48 - $248.15
使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。
推定方法
バリュエーション指標
P/E レシオ
26.81
ROE
19.9%
P/B レシオ
6.40
P/FCF
20.54
粗利益率
-
ROIC
10.6%
収益性レーダー
価値創造（経済的モート）
ROIC
10.6%
WACC
5.9%
ROIC − WACC
+4.7 pp
ROICが資本コストを上回っています。企業は株主のために価値を創出しています。
ファンダメンタル分析基準
合格（18）
- EPS shows upward trend
- EPS CAGR 15.16%
- Price CAGR 12.19%
- ROIC 10.6%
- P/FCF 20.54
- Debt/Equity ratio
- Operating Margin 10.4%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 25.5%
- Revenue Growth 5Y 14.3%
- Analyst Consensus 91% Buy
- Earnings Surprise avg 9.0%
- Earnings Quality (OCF/NI) 1.33
- Share Dilution -3.3%
不合格（6）
- P/B Ratio 6.40
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 5.9% vs 7.9%
- Piotroski F-Score 4/9
データなし（4）
- Gross Margin NaN%
- Dividend Payout NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-スコア
まちまちのシグナル：一部の領域に注意が必要
利益の質
高品質：利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
機関投資家の保有
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. | President, CEO & Director | 64 |
| Mr. John D. Kelly CPA, M.S. | Executive VP, CFO & Treasurer | 48 |
| Mr. J. Ronald Dail | Executive VP & COO | 54 |
| Ms. Hope E. Katz J.D. | Executive VP, General Counsel & Corporate Secretary | - |
| Mr. Kyle D. Featherstone | Chief Accounting Officer & Corporate VP | 44 |
| Mr. Sean Freeburger | Chief Information Officer | - |
| Allie Bovis | Director of Communications | - |
| Elizabeth Entinghe | Corporate Vice President of Corporate Development | - |
| Sarah McHugh | Corporate VP & Chief Marketing Officer | - |
| Ms. Kristen Bruner | Chief Human Resources Officer & Corporate VP | - |
監査リスク
1
取締役会リスク
3
報酬リスク
3
株主権利リスク
6
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容：テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
業績推移
via SEC EDGAR
Latest News
Recent headlines for HURN, sourced from Markets Gazette.
- 5/5/2026NEUTRALHuron Consulting Gr Q1 2026 Earnings Call Transcript
Huron Consulting Group Inc. (HURN) released its Q1 2026 Earnings Call Transcript on May 5, 2026. The transcript provides detailed insights into the company's financial performance, strategic initiatives, and outlook for the upcoming quarters. While specific financial figures and forward-looking statements are discussed, the transcript itself is an informational document rather than a direct announcement of new performance data or significant strategic shifts that would immediately impact the stock price. Investors can use this transcript to gain a deeper understanding of management's perspective and the underlying business drivers.
via Markets Gazette